Related Experiment Videos

Regulation of macrophage lysosomal secretion by adenosine, adenosine phosphate esters, and related structural

Insights

Adenosine and its related compounds, including AMP, ADP, and ATP, inhibit beta-galactosidase secretion in macrophages. This inhibition primarily occurs intracellularly after conversion to adenosine, impacting immune cell function.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Macrophages play a crucial role in the innate immune system, mediating inflammatory responses.
  • Lysosomal enzyme secretion is a key function of macrophages involved in pathogen clearance and tissue remodeling.
  • Purinergic signaling, involving adenosine and its nucleotides, is known to modulate immune cell activity.

Purpose of the Study:

  • To investigate the effect of adenosine and its related nucleotides on zymosan-stimulated beta-galactosidase secretion by mouse peritoneal macrophages.
  • To elucidate the mechanism of inhibition, including the role of cell surface enzymes and adenosine receptors.

Main Methods:

  • Primary mouse peritoneal macrophages were stimulated with zymosan particles.
  • Beta-galactosidase secretion was measured in the presence of various adenosine analogs, nucleotides, and enzyme inhibitors (erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) and alpha, beta -methylene ADP).
  • Theophylline was used to assess the involvement of plasma membrane adenosine receptors.

Main Results:

  • Adenosine, AMP, ADP, and ATP significantly inhibited zymosan-induced beta-galactosidase secretion.
  • Inhibition was potentiated by EHNA, an adenosine deaminase inhibitor, and largely reversed by alpha, beta -methylene ADP, a 5'-nucleotidase inhibitor, indicating conversion to adenosine.
  • Theophylline did not reverse adenosine's inhibitory effect, suggesting intracellular action, while other purine nucleosides also showed inhibitory effects.

Conclusions:

  • Adenosine and its nucleotides are potent inhibitors of macrophage lysosomal enzyme secretion, acting primarily intracellularly after conversion to adenosine.
  • This purinergic regulation highlights a novel mechanism influencing macrophage effector functions.
  • Findings suggest therapeutic potential for purinergic modulators in inflammatory conditions.

Related Concept Videos